Presentation Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES May 23, 2017 REGISTER for free or LOG IN to view this content Clinical Pharma Coronary CAD Pharma DES/BRS/DCB Atrial Fibrillation Heart Rhythm Pharma Factoid Up Next Presentation CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence May 24, 2017 More slides + Presentation Myocardial Damage in Patients With Deferred Stenting After STEMI June 05, 2017 Presentation Outcomes With Boston Scientific Lotus Valve and Edwards Lifesciences Sapien 3 June 06, 2017 We Recommend
Presentation CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence May 24, 2017
Presentation Outcomes With Boston Scientific Lotus Valve and Edwards Lifesciences Sapien 3 June 06, 2017